% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • bocephusbling bocephusbling Aug 15, 2013 7:10 AM Flag

    Ex-US for APOCIII

    While Isis has stated they do not plan to partner APOCIII until the Phase III in extremely high TGs is completed or nearly completed, they may go ahead and license the ex-US rights. ALNY got $22.5 million for its TTR drugs ex-US and ex-Europe rights, plus milestones and mid-teens to mid-twenties royalties. Isis garnering a similar deal for a similar territory would take some risk out of APOCIII.

57.560.00(0.00%)Dec 21 4:00 PMEST